Scinovex
article

Higher viral RNA detection in placenta biopsies than maternal serum in a term infant born to a mother with confirmed SARS-CoV-2 infection

Abstract

The SARS-CoV-2 outbreak was declared a pandemic by the WHO in March 2020. The neonatal population is thought to have a low incidence and severity of the disease, but maternal-to-fetus transmission has not been well studied. We present a term infant born to a mother with mild symptoms of laboratory confirmed SARS-CoV-2 infection seven days prior to cesarean delivery. Four placental biopsies tested by RT-PCR for SARS-CoV-2 were positive, while a nasopharyngeal swab and rectal swab were negative. The infant was not symptomatic. No anti-SARS-CoV-2 maternal antibodies were detected in the infant’s sera through the 28th postnatal day.

COVID-19 Impact on ReproductionPregnancy and preeclampsia studiesPregnancy and Medication ImpactMedicineIncidence (geometry)PopulationTransmission (telecommunications)OutbreakPlacentaPregnancyObstetricsFetusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Citations
0
FWCI
0.00
field-weighted impact
References
18
Percentile
20%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Higher viral RNA detection in placenta biopsies than maternal serum in a term infant born to a mother with confirmed SARS-CoV-2 infection · Scinovex